-
公开(公告)号:US20210115406A1
公开(公告)日:2021-04-22
申请号:US17088828
申请日:2020-11-04
申请人: EMULATE, INC.
发明人: S. Jordan Kerns , Catherine Karalis , Janna Nawroth , Remi Villenave , Jenifer Obrigewitch , Doris Roth , Michael Salmon , Athanasia Apostolou , David Conegliano
摘要: The present invention relates to a combination of microbes, cell culture systems and microfluidic fluidic systems for use in providing a human Intestine On-Chip with optimal intestinal motility. More specifically, in some embodiments, a microfluidic chip containing intestinal epithelial cells co-cultured with intestinal endothelial cells in the presence of bacteria, such as probiotic bacteria, may find use in providing an Intestine-On-Chip for testing intestinal motility function. In some embodiments, an Intestine On-Chip may be used for identifying (testing) therapeutic compounds continuing probiotic microbes or compounds for inducing intestinal motility for use in treating gastrointestinal disorders or diseases related to intestinal function.
-
公开(公告)号:US20230287355A1
公开(公告)日:2023-09-14
申请号:US18083916
申请日:2022-12-19
申请人: EMULATE, INC.
发明人: Remi Villenave , Carolina Lucchesi , Justin Nguyen , Catherine Karalis , Geraldine Hamilton , Buket Baddal , Michael Salmon
CPC分类号: C12N5/0688 , B01L3/502769 , C12N1/20 , C12N2502/00
摘要: The present invention relates to microfluidic fluidic systems and methods for the in vitro modeling diseases of the lung and small airway. In one embodiment, the invention relates to a system for testing responses of a microfluidic Small Airway-on-Chip infected with one or more infectious agents (e.g. respiratory viruses) as a model of respiratory disease exacerbation (e.g. asthma exacerbation). In one embodiment, this disease model on a microfluidic chip allows for a) the testing of anti-inflammatory and/or anti-viral compounds introduced into the system, as well as b) the monitoring of the participation, recruitment and/or movement of immune cells, including the transmigration of cells. In particular, this system provides, in one embodiment, an in-vitro platform for modeling severe asthma as “Severe Asthma-on-Chip.” In some embodiments, this invention provides a model of viral-induced asthma in humans for use in identifying potentially effective treatments.
-
公开(公告)号:US20180230417A1
公开(公告)日:2018-08-16
申请号:US15820011
申请日:2017-11-21
申请人: EMULATE, Inc.
IPC分类号: C12M3/06 , C12M1/12 , C07K16/28 , C12N5/0783 , G01N33/50
CPC分类号: C12M23/16 , B01L3/502753 , B01L2300/0681 , C07K16/2809 , C07K16/2818 , C12M25/02 , C12N5/0636 , C12N5/0652 , C12N5/0679 , C12N5/0697 , C12N2501/999 , C12N2502/13 , C12N2502/23 , C12N2502/28 , C12N2503/04 , C12N2533/90 , C12N2533/92 , G01N33/505 , G01N33/5088
摘要: An in vitro microfluidic gut-on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic culture is described, allowing for interactions between lamina propria-derived cells and gastrointestinal epithelial cells and endothelial cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal tissue, e.g., Crohn's disease, colitis and other inflammatory gastrointestinal disorders. These multicellular, layered microfluidic gut-on-chip further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal deuodejeum, small intestinal ileium, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e. healthy, pre-disease and diseased areas. Additionally, these microfluidic gut-on-chips allow identification of cells and cellular derived factors driving disease states and drug testing for reducing inflammation.
-
公开(公告)号:US11001795B2
公开(公告)日:2021-05-11
申请号:US15819966
申请日:2017-11-21
申请人: EMULATE, Inc.
发明人: S. Jordan Kerns , Jenifer Obrigewitch , Michael Salmon , Magdalena Kasendra , Benjamin Richards Umiker
摘要: An in vitro microfluidic gut-on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic culture is described, allowing for interactions between lamina propria-derived cells and gastrointestinal epithelial cells and endothelial cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal tissue, e.g., Crohn's disease, colitis and other inflammatory gastrointestinal disorders. These multicellular, layered microfluidic gut-on-chip further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal deuodejeum, small intestinal ileium, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e. healthy, pre-disease and diseased areas. Additionally, these microfluidic gut-on-chips allow identification of cells and cellular derived factors driving disease states and drug testing for reducing inflammation.
-
公开(公告)号:US11230688B2
公开(公告)日:2022-01-25
申请号:US15820011
申请日:2017-11-21
申请人: EMULATE, Inc.
摘要: An in vitro microfluidic gut-on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic culture is described, allowing for interactions between lamina propria-derived cells and gastrointestinal epithelial cells and endothelial cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal tissue, e.g., Crohn's disease, colitis and other inflammatory gastrointestinal disorders. These multicellular, layered microfluidic gut-on-chip further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal deuodejeum, small intestinal ileium, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e. healthy, pre-disease and diseased areas. Additionally, these microfluidic gut-on-chips allow identification of cells and cellular derived factors driving disease states and drug testing for reducing inflammation.
-
公开(公告)号:US20180224432A1
公开(公告)日:2018-08-09
申请号:US15819966
申请日:2017-11-21
申请人: EMULATE, Inc.
发明人: S. Jordan Kerns , Jenifer Obrigewitch , Michael Salmon , Magdalena Kasendra , Benjamin Richards Umiker
CPC分类号: C12M23/16 , B01L3/502753 , B01L2300/0681 , C07K16/2809 , C07K16/2818 , C12M25/02 , C12N5/0636 , C12N5/0652 , C12N5/0679 , C12N5/0697 , C12N2501/999 , C12N2502/13 , C12N2502/23 , C12N2502/28 , C12N2503/04 , C12N2533/90 , C12N2533/92 , G01N33/505 , G01N33/5088
摘要: An in vitro microfluidic gut-on-chip is described herein that mimics the structure and at least one function of specific areas of the gastrointestinal system in vivo. In particular, a multicellular, layered, microfluidic culture is described, allowing for interactions between lamina propria-derived cells and gastrointestinal epithelial cells and endothelial cells. This in vitro microfluidic system can be used for modeling inflammatory gastrointestinal tissue, e.g., Crohn's disease, colitis and other inflammatory gastrointestinal disorders. These multicellular, layered microfluidic gut-on-chip further allow for comparisons between types of gastrointestinal tissues, e.g., small intestinal deuodejeum, small intestinal ileium, large intestinal colon, etc., and between disease states of gastrointestinal tissue, i.e. healthy, pre-disease and diseased areas. Additionally, these microfluidic gut-on-chips allow identification of cells and cellular derived factors driving disease states and drug testing for reducing inflammation.
-
公开(公告)号:US20240309331A1
公开(公告)日:2024-09-19
申请号:US18591819
申请日:2024-02-29
申请人: Emulate, Inc.
发明人: S. Jordan Kerns , Catherine Karalis , Janna Nawroth , Remi Villenave , Jenifer Obrigewitch , Doris Roth , Michael Salmon , Athanasia Apostolou , David Conegliano
CPC分类号: C12N5/0679 , C12M23/16 , C12M35/04 , C12M35/08 , C12N1/20 , C12N5/0688 , C12Q1/04 , C12N2500/02 , C12N2502/70 , C12N2506/23 , C12N2537/00
摘要: The present invention relates to a combination of microbes, cell culture systems and microfluidic fluidic systems for use in providing a human Intestine On-Chip with optimal intestinal motility. More specifically, in some embodiments, a microfluidic chip containing intestinal epithelial cells co-cultured with intestinal endothelial cells in the presence of bacteria, such as probiotic bacteria, may find use in providing an Intestine-On-Chip for testing intestinal motility function. In some embodiments, an Intestine On-Chip may be used for identifying (testing) therapeutic compounds continuing probiotic microbes or compounds for inducing intestinal motility for use in treating gastrointestinal disorders or diseases related to intestinal function.
-
公开(公告)号:US11542476B2
公开(公告)日:2023-01-03
申请号:US16692383
申请日:2019-11-22
申请人: EMULATE, INC.
发明人: Remi Villenave , Carolina Lucchesi , Justin Nguyen , Catherine Karalis , Geraldine Hamilton , Buket Baddal , Michael Salmon
摘要: The present invention relates to microfluidic fluidic systems and methods for the in vitro modeling diseases of the lung and small airway. In one embodiment, the invention relates to a system for testing responses of a microfluidic Small Airway-on-Chip infected with one or more infectious agents (e.g. respiratory viruses) as a model of respiratory disease exacerbation (e.g. asthma exacerbation). In one embodiment, this disease model on a microfluidic chip allows for a) the testing of anti-inflammatory and/or anti-viral compounds introduced into the system, as well as b) the monitoring of the participation, recruitment and/or movement of immune cells, including the transmigration of cells. In particular, this system provides, in one embodiment, an in-vitro platform for modeling severe asthma as “Severe Asthma-on-Chip.” In some embodiments, this invention provides a model of viral-induced asthma in humans for use in identifying potentially effective treatments.
-
-
-
-
-
-
-